Annual EBITDA:
-$96.79M-$25.76M(-36.27%)Summary
- As of today, JANX annual EBITDA is -$96.79 million, with the most recent change of -$25.76 million (-36.27%) on December 31, 2024.
- During the last 3 years, JANX annual EBITDA has fallen by -$63.97 million (-194.94%).
- JANX annual EBITDA is now -2470.70% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$44.58M-$10.20M(-29.67%)Summary
- As of today, JANX quarterly EBITDA is -$44.58 million, with the most recent change of -$10.20 million (-29.67%) on June 30, 2025.
- Over the past year, JANX quarterly EBITDA has dropped by -$31.26 million (-234.76%).
- JANX quarterly EBITDA is now -3451.95% below its all-time high of -$1.25 million, reached on September 30, 2020.
Performance
JANX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$142.80M-$31.26M(-28.03%)Summary
- As of today, JANX TTM EBITDA is -$142.80 million, with the most recent change of -$31.26 million (-28.03%) on June 30, 2025.
- Over the past year, JANX TTM EBITDA has dropped by -$78.93 million (-123.60%).
- JANX TTM EBITDA is now -10767.35% below its all-time high of -$1.31 million, reached on March 31, 2020.
Performance
JANX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
JANX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -36.3% | -234.8% | -123.6% |
| 3Y3 Years | -194.9% | -159.9% | -160.0% |
| 5Y5 Years | -2470.7% | -1796.9% | -2803.0% |
JANX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -194.9% | at low | -234.8% | at low | -131.0% | at low |
| 5Y | 5-Year | -2470.7% | at low | -3451.9% | at low | -2803.0% | at low |
| All-Time | All-Time | -2470.7% | at low | -3451.9% | at low | >-9999.0% | at low |
JANX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$44.58M(-29.7%) | -$142.80M(-28.0%) |
| Mar 2025 | - | -$34.38M(-20.6%) | -$111.54M(-15.2%) |
| Dec 2024 | -$96.79M(-36.3%) | -$28.51M(+19.3%) | -$96.79M(-15.4%) |
| Sep 2024 | - | -$35.33M(-165.3%) | -$83.88M(-31.3%) |
| Jun 2024 | - | -$13.32M(+32.2%) | -$63.86M(+9.8%) |
| Mar 2024 | - | -$19.63M(-25.8%) | -$70.83M(+0.3%) |
| Dec 2023 | -$71.02M(-7.2%) | -$15.61M(-1.9%) | -$71.02M(+3.1%) |
| Sep 2023 | - | -$15.31M(+24.5%) | -$73.28M(+3.2%) |
| Jun 2023 | - | -$20.28M(-2.3%) | -$75.74M(-4.3%) |
| Mar 2023 | - | -$19.83M(-11.0%) | -$72.62M(-9.6%) |
| Dec 2022 | -$66.25M | -$17.86M(-0.5%) | -$66.25M(-7.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$17.77M(-3.6%) | -$61.81M(-12.6%) |
| Jun 2022 | - | -$17.15M(-27.4%) | -$54.92M(-24.8%) |
| Mar 2022 | - | -$13.46M(-0.3%) | -$44.00M(-34.1%) |
| Dec 2021 | -$32.82M(-399.9%) | -$13.43M(-23.4%) | -$32.82M(-56.0%) |
| Sep 2021 | - | -$10.88M(-74.3%) | -$21.04M(-84.3%) |
| Jun 2021 | - | -$6.24M(-174.2%) | -$11.41M(-51.7%) |
| Mar 2021 | - | -$2.27M(-38.2%) | -$7.53M(-14.6%) |
| Dec 2020 | -$6.57M(-74.4%) | -$1.65M(-31.2%) | -$6.57M(-33.5%) |
| Sep 2020 | - | -$1.25M(+46.6%) | -$4.92M(-34.3%) |
| Jun 2020 | - | -$2.35M(-78.8%) | -$3.66M(-178.8%) |
| Mar 2020 | - | -$1.31M | -$1.31M |
| Dec 2019 | -$3.77M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Janux Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Janux Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Janux Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of JANX is -$96.79M
What is the all-time high annual EBITDA for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual EBITDA is -$3.77M
What is Janux Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, JANX annual EBITDA has changed by -$25.76M (-36.27%)
What is Janux Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of JANX is -$44.58M
What is the all-time high quarterly EBITDA for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly EBITDA is -$1.25M
What is Janux Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, JANX quarterly EBITDA has changed by -$31.26M (-234.76%)
What is Janux Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of JANX is -$142.80M
What is the all-time high TTM EBITDA for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM EBITDA is -$1.31M
What is Janux Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, JANX TTM EBITDA has changed by -$78.93M (-123.60%)